Dietary squalene supplementation improves DSS-induced acute colitis by downregulating p38 MAPK and NFkB signaling pathways

Molecular Nutrition and Food Research

Volumn 59, Issue 2, 2015, Pages 284-292

  Sánchez Fidalgo, Susana ^a   Villegas, Isabel ^a   Rosillo, Maria Ángeles ^a   Aparicio Soto, Marina ^a   de la Lastra, Catalina Alarcón ^a  

^a UNIVERSITY OF SEVILLE   (Spain)

Author keywords

Dextran sulfate sodium; MAPK; NFkB; Squalene; Ulcerative colitis

Indexed keywords

MUS;

ANTIINFLAMMATORY AGENT; ANTIOXIDANT; CYCLOOXYGENASE 2; DEXTRAN SULFATE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; MITOGEN ACTIVATED PROTEIN KINASE P38; NFE2L2 PROTEIN, MOUSE; NOS2 PROTEIN, MOUSE; PTGS2 PROTEIN, MOUSE; SQUALENE; TRANSCRIPTION FACTOR NRF2; TUMOR NECROSIS FACTOR ALPHA;

ACUTE DISEASE; ANIMAL; BLOOD; C57BL MOUSE; CHEMICALLY INDUCED; COLITIS; COLON; DIET SUPPLEMENTATION; DOWN REGULATION; DRUG EFFECTS; FEMALE; GENETICS; METABOLISM; MOUSE; SIGNAL TRANSDUCTION;

ACUTE DISEASE; ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; COLITIS; COLON; CYCLOOXYGENASE 2; DEXTRAN SULFATE; DIETARY SUPPLEMENTS; DOWN-REGULATION; FEMALE; INTERLEUKIN-1BETA; MICE; MICE, INBRED C57BL; NF-E2-RELATED FACTOR 2; NF-KAPPA B; NITRIC OXIDE SYNTHASE TYPE II; P38 MITOGEN-ACTIVATED PROTEIN KINASES; SIGNAL TRANSDUCTION; SQUALENE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84922805496     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201400518     Document Type: Article

References (56)

1. Kolios, G., Valatas, V., Ward, S. G., Nitric oxide in inflammatory bowel disease: a universal messenger in an unsolved puzzle. Immunology 2004, 113, 427-437.
2. Braus, N. A., Elliott, D. E., Advances in the pathogenesis and treatment of IBD. Clin. Immunol. 2009, 132, 1-9.
3. Wei, J., Feng, J., Signaling pathways associated with inflammatory bowel disease. Recent Pat. Inflamm. Allergy Drug Discov. 2010, 4, 105-117.
4. Perrier, C., Rutgeerts, P., Cytokine blockade in inflammatory bowel diseases. Immunotherapy 2011, 3, 1341-1352.
5. Bamias, G., Kaltsa, G., Ladas, S. D., Cytokines in the pathogenesis of ulcerative colitis. Discov. Med. 2011, 11, 459-467.
6. Fu, X. Y., STAT3 in immune responses and inflammatory bowel diseases. Cell Res. 2006, 16, 214-219.
7. Leonard, W. J., O'Shea, J. J., Jaks and STATs: biological implications. Annu. Rev. Immunol. 1998, 16, 293-322.
8. Musso, A., Dentelli, P., Carlino, A., Chiusa, L. et al., Signal transducers and activators of transcription 3 signaling pathway: an essential mediator of inflammatory bowel disease and other forms of intestinal inflammation. Inflamm. Bowel Dis. 2005, 11, 91-98
9. Li, W., Khor, T. O., Xu, C., Shen, G. et al., Activation of Nrf2-antioxidant signaling attenuates NFkappaB inflammatory response and elicits apoptosis. Biochem. Pharmacol. 2008, 76, 1485-1489.
10. Belkaid, Y., Rouse, B. T., Natural regulatory T cells in infectious disease. Nat. Immunol. 2005, 6, 353-360.
11. Yamaguchi, T., Sakaguchi, S., Regulatory T cells in immune surveillance and treatment of cancer. Semin. Cancer Biol. 2006, 16, 115-123.
12. Wood, K. J., Sakaguchi, S., Regulatory T cells in transplantation tolerance. Nat. Rev. Immunol. 2003, 3, 199-210.
13. + regulatory T cells. J. Immunol. 2007, 178, 2458-2468.
14. + regulatory T cells suppress Th17-responses in an experimental colitis model. Dig. Dis. Sci. 2011, 56, 376-386.
15. Matyas, G. R., Wassef, N. M., Rao, M., Alving, C. R., Induction and detection of antibodies to squalene. J. Immunol. Methods 2000, 245, 1-14.
16. Newmark, H. L., Squalene, olive oil, and cancer risk: a review and hypothesis. Cancer Epidemiol. Biomarkers Prev. 1997, 6, 1101-1103.
17. Kim, S. K., Karadeniz, F., Biological importance and applications of squalene and squalane. Adv. Food Nutr. Res. 2012, 65, 223-233.
18. Reddy, L. H., Couvreur, P., Squalene: a natural triterpene for use in disease management and therapy. Adv. Drug Deliv. Rev. 2009, 61, 1412-1426.
19. Kabuto, H., Yamanushi, T. T., Janjua, N., Takayama, F. et al., Effects of squalene/squalane on dopamine levels, antioxidant enzyme activity, and fatty acid composition in the striatum of Parkinson's disease mouse model. J. Oleo Sci. 2013, 62, 21-28.
20. Sabeena-Farvin, K. H., Anandan, R., Kumar, S. H., Shiny, K. S. et al., Effect of squalene on tissue defense system in isoproterenol-induced myocardial infarction in rats. Pharmacol. Res. 2004, 50, 231-236.
21. Motawi, T. M., Sadik, N. A., Refaat, A., Cytoprotective effects of DL-alpha-lipoic acid or squalene on cyclophosphamide-induced oxidative injury: an experimental study on rat myocardium, testicles and urinary bladder. Food Chem. Toxicol. 2010, 48, 2326-2336.
22. Ghanbari, R., Anwar, F., Alkharfy, K. M., Gilani, A. H et al., Valuable nutrients and functional bioactives in different parts of olive (Olea europaea L.)-a review. Int. J. Mol. Sci. 2012, 13, 3291-32340.
23. Guillen, N., Acin, S., Navarro, M. A., Perona, J. S. et al., Squalene in a sex-dependent manner modulates atherosclerotic lesion which correlates with hepatic fat content in apoE-knockout male mice. Atherosclerosis 2008, 197, 72-83.
24. Melgar, S., Karlsson, A., Michaëlsson, E., Acute colitis induced by dextran sulfate sodium progresses to chronicity in C57BL/6 but not in BALB/c mice: correlation between symptoms and inflammation. Am. J. Physiol. Gastrointest. Liver Physiol. 2005, 288, G1328-G1338.
25. Sánchez-Fidalgo, S., Cárdeno, A., Sánchez-Hidalgo, M., Aparicio-Soto, M. et al., Dietary unsaponifiable fraction from extra virgin olive oil supplementation attenuates acute ulcerative colitis in mice. Eur. J. Pharm. Sci. 2012, 48, 572-581.
26. Dieleman, L. A., Palmen, M. J., Akol, H., Bloemena, E. et al., Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines. Clin. Exp. Immunol. 1998, 114, 385-391.
27. Sanchez-Hidalgo, M., Martin, A. R., Villegas, I., Alarcon De La Lastra, C., Rosiglitazone, an agonist of peroxisome proliferator-activated receptor gamma, reduces chronic colonic inflammation in rats. Biochem. Pharmacol. 2005, 69, 1733-1744.
28. Surh, Y. J., NF-kappa B and Nrf2 as potential chemopreventive targets of some anti-inflammatory and antioxidative phytonutrients with anti-inflammatory and antioxidative activities. Asia Pac. J. Clin. Nutr. 2008, 17, 269-272.
29. McGuckin, M. A., Eri, R., Simms, L. A., Florin, T. H. et al., Intestinal barrier dysfunction in inflammatory bowel diseases. Inflamm. Bowel Dis. 2009, 15, 100-113.
30. Bento, A. F., Leite, D. F., Claudino, R. F., Hara, D. B. et al., The selective nonpeptide CXCR2 antagonist SB225002 ameliorates acute experimental colitis in mice. J. Leukoc. Biol. 2008, 84, 1213-1221.
31. Sánchez-Fidalgo, S., Villegas, I., Cárdeno, A., Talero, E. et al., Extra-virgin olive oil-enriched diet modulates DSS-colitis-associated colon carcinogenesis in mice. Clin. Nutr. 2010, 29, 663-673.
32. Sánchez-Fidalgo, S., Cárdeno, A., Villegas, I., Talero, E. et al., Dietary supplementation of resveratrol attenuates chronic colonic inflammation in mice. Eur. J. Pharmacol. 2010, 633, 78-84.
33. Tsatsanis, C., Androulidaki, A., Venihaki, M., Margioris, A. N., Signalling networks regulating cyclooxygenase-2. Int. J. Biochem. Cell Biol. 2006, 38, 1654-1661.
34. Corona, G., Deiana, M., Incani, A., Vauzour, D. et al., Inhibition of p38/CREB phosphorylation and COX-2 expression by olive oil polyphenols underlies their anti-proliferative effects. Biochem. Biophys. Res. Commun. 2007, 362, 606-611.
35. Kaminska, B., MAPK signalling pathways as molecular targets for anti-inflammatory therapy-from molecular mechanisms to therapeutic benefits. Biochim. Biophys. Acta 2005, 1754, 253-262.
36. Rosillo, M. A., Sanchez-Hidalgo, M., Cárdeno, A., de la Lastra, C. A., Protective effect of ellagic acid, a natural polyphenolic compound, in a murine model of Crohn's disease. Biochem. Pharmacol. 2011, 82, 737-745.
37. Kim, J. M., Jung, H. Y., Lee, J. Y., Youn, J. et al., Mitogen-activated protein kinase and activator protein-1 dependent signals are essential for bacteroides fragilis enterotoxininduced enteritis. Eur. J. Immunol. 2005, 35, 2648-2657.
38. Wullaert, A., Bonnet, M. C., Pasparakis, M., NFjB in the regulation of epithelial homeostasis and inflammation. Cell Res. 2011, 21, 146-158.
39. Rosillo, M. A., Sánchez-Hidalgo, M., Cárdeno, A., Aparicio-Soto, M. et al., Dietary supplementation of an ellagic acid-enriched pomegranate extract attenuates chronic colonic inflammation in rats. Pharmacol. Res. 2012, 66, 235-242.
40. Sánchez-Fidalgo, S., Cárdeno, A., Sánchez-Hidalgo, M., Aparicio-Soto, M. et al., Dietary extra virgin olive oil polyphenols supplementation modulates DSS-induced chronic colitis in mice. J. Nutr. Biochem. 2013, 24, 1401-1413.
41. Sánchez-Fidalgo, S., Cárdeno, A., Sánchez-Hidalgo, M., Aparicio-Soto, M. et al., Dietary unsaponifiable fraction from extra virgin olive oil supplementation attenuates acute ulcerative colitis in mice. Eur. J. Pharm. Sci. 2012, 48, 572-581.
42. Itzkowitz, S. H., Molecular biology of dysplasia and cancer in inflammatory bowel disease. Gastroenterol. Clin. North Am. 2006, 35, 553-371.
43. Coskun, M., Olsen, J., Seidelin, J. B., Nielsen, O. H., MAP kinases in inflammatory bowel disease. Clin. Chim. Acta 2011, 412, 513-520.
44. Khor, T. O., Huang, M. T., Kwon, K. H., Chan, J. Y. et al., Nrf2-deficient mice have an increased susceptibility to dextran sulfate sodium-induced colitis. Cancer Res. 2006, 66, 11580-1154.
45. Coskun, M., Salem, M., Pedersen, J., Nielsen, O. H., Involvement of JAK/STAT signaling in the pathogenesis of inflammatory bowel disease. Pharmacol. Res. 2013, 76, 1-8.
46. Lovato, P., Brender, C., Agnholt, J., Kelsen, J. et al., Constitutive STAT3 activation in intestinal T cells from patients with Crohn's disease. J. Biol. Chem. 2003, 278, 16777-16781.
47. Mudter, J., Weigmann, B., Bartsch, B., Kiesslich, R. et al., Activation pattern of signal transducers and activators of transcription (STAT) factors in inflammatory bowel diseases. Am. J. Gastroenterol. 2005, 100, 64-72.
48. Atreya, R., Mudter, J., Finotto, S., Mullberg, J. et al., Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in Crohn disease and experimental colitis in vivo. Nat. Med. 2000, 6, 583-588.
49. Yamamoto, M., Yoshizaki, K., Kishimoto, T., Ito, H., IL-6 is required for the development of Th1 cell-mediated murine colitis. J. Immunol. 2000, 164, 4878-4882.
50. Suzuki, A., Hanada, T., Mitsuyama, K., Yoshida, T. et al., CIS3/SOCS3/SSI3 plays a negative regulatory role in STAT3 activation and intestinal inflammation. J. Exp. Med. 2001, 193, 471-481.
51. Siegmund, B., Lehr, H. A., Fantuzzi, G., Leptin: a pivotal mediator of intestinal inflammation in mice. Gastroenterology 2002, 122, 2011-2025.
52. Marín, M., María Giner, R., Ríos, J. L., Recio, M. C., Intestinal anti-inflammatory activity of ellagic acid in the acute and chronic dextrane sulfate sodium models of mice colitis. J. Ethnopharmacol. 2013, 150, 925-934.
53. Liu, L., Liu, Y. L., Liu, G. X., Chen, X. et al., Curcumin ameliorates dextran sulfate sodium-induced experimental colitis by blocking STAT3 signaling pathway. Int. Immunopharmacol. 2013, 17, 314-320.
54. Izcue, A., Coombes, J. L., Powrie, F., Regulatory lymphocytes and intestinal inflammation. Annu. Rev. Immunol. 2009, 27, 313-338.
55. Sakaguchi, S., Wing, K., Onishi, Y., Prieto-Martin, P. et al., Regulatory T cells: how do they suppress immune responses? Int. Immunol. 2009, 21, 1105-1111.
56. Kim, H. R., Lee, A., Choi, E. J., Kie, J. H. et al., Attenuation of experimental colitis in glutathione peroxidase 1 and catalase double knockout mice through enhancing regulatory T cell function. PLoS One 2014, 9, e95332.